Tarek AbdelKader has been hired as the Chief Technology Officer of Muse Finance, a start-up business finance company. To support the company’s plans to grow in 2022, AbdelKader joins as a seasoned CTO with previous experience at financial firms, such as The Co-Operative Bank and Think Money Group, and software providers Blinx Solutions and Meta Software.
AbdelKader was instrumental in helping The Co-operative Financial Services save $1 million a year across 10,000 loan settlement applications by implementing technology upgrades. When it comes to technology service delivery, AbdelKader is an industry thought leader who has achieved results with both internal and external stakeholders. As Muse Finance continues to grow, Tarek’s presence is greatly appreciated.
AbdelKader will be in charge of Muse Finance’s transition to a serverless architecture model, which will allow for greater scalability and security for its users. Aside from the backend ledger, he will be in charge of overseeing the integration of Web3 technologies and the use of AI in Muse’s credit decisioning.
Tarek will also contribute to the digitisation of Muse products by integrating end-to-end customer Web and mobile journey automations with the goal of expediting customer finance applications and providing them with access to funds in minutes rather than days.
CTO Tarek AbdelKader of Muse said: “I’m looking forward to introducing cutting-edge technology and changing how our existing FinTech processes and operations work.” Muse Finance’s work is truly exciting, and I’m looking forward to being a part of its continued expansion. “
It took some time to find the right partner to help us scale in this next phase of the business, “said Muse Finance Founder & CEO Ann Marie Juliano. It was a no-brainer to hire Tarek because of his extensive background in coding and his ability to get right into the action. Tarek is a great addition to our team. When it comes to providing our clients with the security and financial resources they require, he has already made a significant contribution.
Also read: New technology is being introduced by ISA Pharmaceuticals to test cancers